BioPharmaDispatch Conference.

The Challenges of 2021 and Beyond

Sydney and 'Virtual'
17 May 2021

The Conference.

A Day of Powerful Talks
17 May 2021
Ivy Ballroom, Level 1, 320 George Street, Sydney

About BPD.

What is the BPD conference?

The annual event of BioPharmaDispatch is a platform for the biopharmaceutical industry, its leaders, patient groups and key decision-makers to discuss issues impacting access to the latest healthcare technologies


A hybrid in-person and virtual event, the day features a range of speakers and panels. People can register to attend in person or virtually.


Organisations can also request 'bespoke' registration packages that provide a combination of in-person and virtual attendance. This includes a 'license' for unlimited virtual attendance. Please contact for more information.









More speakers will be added once confirmed



Conference Agenda.

7.30am - Patient group breakfast featuring Q&A with PBAC chair Professor Andrew Wilson and deputy chair Jo Watson
8.30am - Venue opens for full conference
8.55am - Conference welcome by host Rae Johnston
Official open
Health minister Greg Hunt
The pre-conditions for change
 Will Delaat AM, former chair, Medicines Australia
David Learmonth, former deputy secretary, Department of Health
Achieving change
Jane Halton AO PSM, chair, CEPI and GBMA
The PBS and the law

Felicity McNeill PSM, Better Access Australia

Kelly Griffiths, Gadens

Making patient input to decision-making real

Catherine Holliday, Centre for Community-Driven Research

The regional and global industry perspective

Chris Hourigan, company group chairman, Asia Pacific, Janssen

The patient perspective

Annie Madden, Harm Reduction Australia

Melanie Funk, Eczema Support Australia

Nicole Cooper

The PBAC and change

Professor Andrew Wilson

The 'latest' chemotherapy review
David Slade, Slade Pharmacy
What is happening in New Zealand?
Dr Graeme Jarvis, CEO, Medicines New Zealand
Australia’s vaccines policy
Dr Brendan Shaw, Shawview Consulting
Jennifer Herz, Biointelect
The future direction of HTA in decision-making

Liz de Somer, MA

Dr Rachel David, Private Healthcare Australia

Ian Burgess, MTAA

The future community pharmacy

Trent Twomey, national president, Pharmacy Guild of Australia

Budget 2021-22 - the politics

Jody Fassina, Insight Strategy

Nick Campbell, NEXUS

The industry and the 2021-22 Budget

Michael Azrak, MSD

Ashraf Al-Ouf, Bayer

Australia and the COVID-19 vaccine

Liz Chatwin, AstraZeneca

Anne Harris, Pfizer

The opportunity of data

Peter Cronin, Prospection

The COVID-19 vaccine communication challenge

Melissa Millard, AstraZeneca

Helen Han, Pfizer

Joanne Cleary, Seqirus

Anne-Marie Sparrow, Cube

The opportunity of clinical trials in Australia

James McAdam, BMS

Zoe Armstrong, MSD

The industry, system stewardship and achieving change

Neil MacGregor, BMS

Christi Kelsey, GSK

Jeppe Theisen, Novo Nordisk

6.00pm - conference close


Register for the BPD Conference.